Although the diagnosis of sleep apnea syndrome (SAS) was defined in the third edition of the International Classification of Sleep Disorders (ICSD-3) (1) published in 2014 by the American Academy of Sleep Medicine, there was no statement about the severity of SAS. Currently, the apneahypopnea index (AHI) is generally used to indicate the severity of SAS; however, there are sex differences in the frequency of occurrence of sleep apnea, which tends to be low in women. The severity of SAS can be determined from the associated complications and/or secondary diseases, and it is problematic to determine the severity using only the AHI, which is the number of apnea or hypopnea events that take place during 1 hour of sleep. For this reason, there was no statement about the severity of SAS in ICSD-3.
sion in sleep apnea (4) . However, whether the number of times per hour or the duration of exposure to hypoxia is more influential is unclear at present. Even in patients with the same AHI, there is a wide range in the severity of the decreases in oxygen saturation accompanying apnea and hypopnea, and in some cases, exacerbation only occurs during rapid eye movement sleep. The desaturation is alleviated by aging and exacerbated by an increase in the body mass index (BMI); of note, women typically weigh less than men. Therefore, the severity of SAS cannot be determined based solely on the number of desaturation events.
Similar to the estimated glomerular filtration rate for the detection of chronic kidney disease, a new index representing the severity of SAS that considers the prognosis, sex differences, age, increase in the BMI, hypoxia exposure, and the number of apnea or hypopnea events per hour is needed.
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